The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2, Supplement 2 , Pages S402-S407 , February 2008

9. Anaphylaxis

  • F. Estelle R. Simons, MD, FRCPC

      Affiliations

    • Corresponding Author InformationReprint requests: F. Estelle R. Simons, MD, FRCPC, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9.

Received 30 May 2007 ,Revised 15 August 2007 ,Accepted 16 August 2007.

References 

  1. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391–397
  2. Simons FER, Frew AJ, Ansotegui IJ, Bochner BS, Finkelman F, Golden DBK, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007;120:S2–S24
  3. Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97:596–602
  4. Clark S, Gaeta TJ, Kamarthi GS, Camargo CA. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Ann Epidemiol. 2006;16:696–700
  5. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119:1016–1018
  6. Pumphrey RSH, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol. 2007;119:1018–1019
  7. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol. 2007;98:252–257
  8. Prussin C, Metcalfe DD. 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2006;117:S450–S456
  9. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CMM, Tsai M. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23:749–786
  10. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol. 2006;117:1214–1225
  11. Jensen BM, Metcalfe DD, Gilfillan AM. Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation. Inflamm Allergy Drug Targets. 2007;6:57–62
  12. Yokoi H, Myers A, Matsumoto K, Crocker PR, Saito H, Bochner BS. Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy. 2006;61:769–776
  13. Olivera A, Mizugishi K, Tikhonova A, Ciaccia L, Odom S, Proia RL, et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity. 2007;26:287–297
  14. Plager DA, Weiss EA, Kephart GM, Mocharla RM, Matsumoto R, Checkel JL, et al. Identification of basophils by a mAb directed against pro-major basic protein 1. J Allergy Clin Immunol. 2006;117:626–634
  15. Chang TW, Shiung Yu-Y. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol. 2006;117:1203–1212
  16. Finkelman FD, Rothenberg ME, Brandt EB, Morris SC, Strait RT. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol. 2005;115:449–457
  17. Simons FER. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol. 2006;117:367–377
  18. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006;26:451–463
  19. Vadas P, Gold M, Perelman B, Liss G, Lack G, Blyth T, et al. Platelet-activating factor, PAF-acetylhydrolase and severe anaphylaxis. N Engl J Med. 2008;358:28–35
  20. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115:S483–S523
  21. Golden DBK. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol. 2005;115:439–447
  22. Golden DBK, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med. 2004;351:668–674
  23. Klein-Tebbe J, Erdmann S, Knol EF, MacGlashan DW, Poulsen LK, Gibbs BF. Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Arch Allergy Immunol. 2006;141:79–90
  24. Jappe U, Raulf-Heimsoth M, Hoffmann M, Burow G, Hubsch-Muller C, Enk A. In vitro Hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy. 2006;61:1220–1229
  25. Golden DBK, Breisch NL, Hamilton RG, Guralnick MW, Greene A, Craig TJ, et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol. 2006;117:670–675
  26. Muller UR, Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol. 2005;115:606–610
  27. Stumpf JL, Shehab N, Patel AC. Safety of angiotensin-converting enzyme inhibitors in patients with insect venom allergies. Ann Pharmacother. 2006;40:699–703
  28. Sicherer SH, Sampson HA. 9. Food allergy. J Allergy Clin Immunol. 2006;117:S470–S475
  29. Sampson HA. Update on food allergy. J Allergy Clin Immunol. 2004;113:805–819
  30. Greenberger PA. 8. Drug allergy. J Allergy Clin Immunol. 2006;117:S464–S470
  31. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol. 2006;6:476–481
  32. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2007;119:780–791
  33. Leung DYM, Sampson HA, Yunginger JW, Burks AW, Schneider LC, Wortel CH, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003;348:986–993
  34. Simons FER. Anaphylaxis: evidence-based long-term risk reduction in the community. Immunol Allergy Clin North Am. 2007;27:231–248
  35. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005;95:217–226
  36. Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol. 2004;113:837–844
  37. Rawas-Qalaji MM, Simons FER, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose-equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol. 2006;117:398–403
  38. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?. Int J Cardiol. 2006;110:7–14
  39. Sheikh A, ten Broek VM, Brown SGA, Simons FER. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev. 2007;1:CD006160
  40. Simons FER. Advances in H1-antihistamines. N Engl J Med. 2004;351:2203–2217

 Disclosure of potential conflict of interest: The author has declared that she has no conflict of interest.

PII: S0091-6749(07)01723-X

doi: 10.1016/j.jaci.2007.08.061

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2, Supplement 2 , Pages S402-S407 , February 2008

Article Tools

* Image Usage & Resolution